Overview
Changes in Myocardial Biomechanics and Early Short-term Doxycycline Therapy in Patients With Primary Anterior STEMI
Status:
Unknown status
Unknown status
Trial end date:
2017-06-01
2017-06-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of the study is to investigate the changes of myocardial biomechanics and efficacy of doxycycline in patients with primary anterior STEMI.Phase:
Phase 2/Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Russian Academy of Medical SciencesTreatments:
Doxycycline
Criteria
Inclusion Criteria:- age ≥ 18 and ≤ 75 years at time of randomization (18 years and older)
- ST-elevation Q wave myocardial infarction
- term admission to an intensive care unit (ICU) in the first 24 hours of onset
- the reperfusion of the infarct-related coronary artery is not later than 24 hours
after the initial onset of acute transmural myocardial infarction
- written the informed consent to participate in research
Exclusion Criteria:
- atrial fibrillation, a permanent form
- valvular heart disease
- severe comorbidity
- acute heart failure according to the Killip classification IV FC (functional class)
- history of chronic heart failure (NYHA III-IV)
- poor image quality for Echocardiography
- sinus bradycardia - heart rate of under 50 beats per minute, interventricular
conduction delay (QRS > 0,11 s.) and atrioventricular block II-III degree